1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key Benefits to the Stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Processes
3. EXECUTIVE SUMMARY
3.1. Key Findings
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. GLOBAL BIOLOGICS MARKET BY PRODUCT TYPE
5.1. Introduction
5.2. Monoclonal Antibodies
5.2.1. Market Opportunities and Trends
5.2.2. Growth Prospects
5.2.3. Geographic Lucrativeness
5.3. Vaccines
5.3.1. Market Opportunities and Trends
5.3.2. Growth Prospects
5.3.3. Geographic Lucrativeness
5.4. Recombinant Proteins
5.4.1. Market Opportunities and Trends
5.4.2. Growth Prospects
5.4.3. Geographic Lucrativeness
5.5. Gene Therapy
5.5.1. Market Opportunities and Trends
5.5.2. Growth Prospects
5.5.3. Geographic Lucrativeness
5.6. Cellular-based Biologics
5.6.1. Market Opportunities and Trends
5.6.2. Growth Prospects
5.6.3. Geographic Lucrativeness
5.7. Others
5.7.1. Market Opportunities and Trends
5.7.2. Growth Prospects
5.7.3. Geographic Lucrativeness
6. GLOBAL BIOLOGICS MARKET BY APPLICATION
6.1. Introduction
6.2. Oncology
6.2.1. Market Opportunities and Trends
6.2.2. Growth Prospects
6.2.3. Geographic Lucrativeness
6.3. Neurology
6.3.1. Market Opportunities and Trends
6.3.2. Growth Prospects
6.3.3. Geographic Lucrativeness
6.4. Cardiology
6.4.1. Market Opportunities and Trends
6.4.2. Growth Prospects
6.4.3. Geographic Lucrativeness
6.5. Hematology
6.5.1. Market Opportunities and Trends
6.5.2. Growth Prospects
6.5.3. Geographic Lucrativeness
6.6. Autoimmune Diseases
6.6.1. Market Opportunities and Trends
6.6.2. Growth Prospects
6.6.3. Geographic Lucrativeness
6.7. Infectious Diseases
6.7.1. Market Opportunities and Trends
6.7.2. Growth Prospects
6.7.3. Geographic Lucrativeness
6.8. Others
6.8.1. Market Opportunities and Trends
6.8.2. Growth Prospects
6.8.3. Geographic Lucrativeness
7. GLOBAL BIOLOGICS MARKET BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. By Product Type
7.2.2. By Application
7.2.3. By Country
7.2.3.1. U.S.
7.2.3.1.1. Market Opportunities and Trends
7.2.3.1.2. Growth Prospects
7.2.3.2. Canada
7.2.3.2.1. Market Opportunities and Trends
7.2.3.2.2. Growth Prospects
7.2.3.3. Mexico
7.2.3.3.1. Market Opportunities and Trends
7.2.3.3.2. Growth Prospects
7.3. South America
7.3.1. By Product Type
7.3.2. By Application
7.3.3. By Country
7.3.3.1. Brazil
7.3.3.1.1. Market Opportunities and Trends
7.3.3.1.2. Growth Prospects
7.3.3.2. Argentina
7.3.3.2.1. Market Opportunities and Trends
7.3.3.2.2. Growth Prospects
7.3.3.3. Others
7.3.3.3.1. Market Opportunities and Trends
7.3.3.3.2. Growth Prospects
7.4. Europe
7.4.1. By Product Type
7.4.2. By Application
7.4.3. By Country
7.4.3.1. United Kingdom
7.4.3.1.1. Market Opportunities and Trends
7.4.3.1.2. Growth Prospects
7.4.3.2. Germany
7.4.3.2.1. Market Opportunities and Trends
7.4.3.2.2. Growth Prospects
7.4.3.3. France
7.4.3.3.1. Market Opportunities and Trends
7.4.3.3.2. Growth Prospects
7.4.3.4. Italy
7.4.3.4.1. Market Opportunities and Trends
7.4.3.4.2. Growth Prospects
7.4.3.5. Spain
7.4.3.5.1. Market Opportunities and Trends
7.4.3.5.2. Growth Prospects
7.4.3.6. Others
7.4.3.6.1. Market Opportunities and Trends
7.4.3.6.2. Growth Prospects
7.5. Middle East and Africa
7.5.1. By Product Type
7.5.2. By Application
7.5.3. By Country
7.5.3.1. Saudi Arabia
7.5.3.1.1. Market Opportunities and Trends
7.5.3.1.2. Growth Prospects
7.5.3.2. UAE
7.5.3.2.1. Market Opportunities and Trends
7.5.3.2.2. Growth Prospects
7.5.3.3. South Africa
7.5.3.3.1. Market Opportunities and Trends
7.5.3.3.2. Growth Prospects
7.6. Asia Pacific
7.6.1. By Product Type
7.6.2. By Application
7.6.3. By Country
7.6.3.1. China
7.6.3.1.1. Market Opportunities and Trends
7.6.3.1.2. Growth Prospects
7.6.3.2. Japan
7.6.3.2.1. Market Opportunities and Trends
7.6.3.2.2. Growth Prospects
7.6.3.3. India
7.6.3.3.1. Market Opportunities and Trends
7.6.3.3.2. Growth Prospects
7.6.3.4. Indonesia
7.6.3.4.1. Market Opportunities and Trends
7.6.3.4.2. Growth Prospects
7.6.3.5. South Korea
7.6.3.5.1. Market Opportunities and Trends
7.6.3.5.2. Growth Prospects
7.6.3.6. Taiwan
7.6.3.6.1. Market Opportunities and Trends
7.6.3.6.2. Growth Prospects
7.6.3.7. Thailand
7.6.3.7.1. Market Opportunities and Trends
7.6.3.7.2. Growth Prospects
7.6.3.8. Others
7.6.3.8.1. Market Opportunities and Trends
7.6.3.8.2. Growth Prospects
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Market Share Analysis
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Competitive Dashboard
9. COMPANY PROFILES
9.1. Hoffmann-La Roche AG
9.2. Amgen Inc.
9.3. AbbVie Inc.
9.4. Novo Nordisk A/S
9.5. Johnson & Johnson
9.6. Takeda Pharmaceutical Company
9.7. Alexion Pharmaceuticals
9.8. Samsung Biologics
9.9. UCB S.A.
9.10. Merck & Co. Inc
9.11. Eli Lilly and Company
9.12. Sanofi SA